3 Polen Capital Hims & Hers Health Trades
Polen Capital started to build up the position in Hims & Hers Health in Q2 2025. Since then they sold 13.9k shares. The investor completely sold their stake between Q3 2025 and Q4 2025.
News about Hims & Hers Health Inc - Ordinary Shares - Class A and Polen Capital
Hims & Hers: Capitalizing On The GLP-1 Rush Before The Window Closes (Rating Upgrade)
I expect price sensitive consumers to flood the market for compounded GLP-1 drugs before the 60-day FDA grace period for semaglutide compounders. HIMS projec...
Short Seller Hunterbrook Slams Hims & Hers (HIMS) Stock in New Report
Hims & Hers Health (NYSE: HIMS ) stock is taking a tumble after Hunterbrook Media released a short report on the telehealth company. Hunterbrook operates an ...
Hims & Hers: Market Blows Off Short Report
Spruce Capital Management issued a short report on Hims & Hers Health, Inc., but the call only forecast downside risk to $5. Read more about HIMS stock here.
Hims & Hers Health''s Return On Capital Employed Overview
According to Benzinga Pro data, during Q4, Hims & Hers Health (NYSE: HIMS ) posted sales of $167.20 million. Earnings were up 42.11%, but Hims & Hers Health ...